共 35 条
[1]
Ahsan F., Rivas I.P., Khan M.A., Torres Suarez A.I., Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages, J Control Release, 79, pp. 29-40, (2002)
[2]
Benita S., Microencapsulation methods and industrial applications, (2006)
[3]
Borborema S.E., Schwendener R.A., Osso J.A., de Andrade H.F., do Nascimento N., Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages, Int J Antimicrob Agents, 38, pp. 341-347, (2011)
[4]
Chowdhary S.J., Chowdhary A., Kashaw S., Macrophage targeting: a strategy for leishmaniasis specific delivery, Int J Pharm Pharm Sci, 8, pp. 16-26, (2016)
[5]
Dandagi P.M., Mastiholimath V.S., Patil M.B., Gupta M.K., Biodegradable microparticulate system of captopril, Int J Pharm, 307, pp. 83-88, (2006)
[6]
Das S., Khan W., Mohsin S., Kumar N., Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation, Polym Adv Technol, 22, pp. 172-179, (2011)
[7]
Date A.A., Joshi M.D., Patravale V.B., Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv Drug Deliv Rev, 59, pp. 505-521, (2007)
[8]
Desjeux P., Human leishmaniases: epidemiology and public health aspects, World Health Stat Q, 45, pp. 267-275, (1992)
[9]
Elzoghby A.O., Samy W.M., Elgindy N.A., Albumin-based nanoparticles as potential controlled release drug delivery systems, J Control Release, 157, pp. 168-182, (2012)
[10]
Fouladvand M., Barazesh A., Farokhzad F., Malekizadeh H., Sartavi K., Evaluation of invitro anti-leishmanial activity of some brown, green and red algae from the Persian Gulf, Eur Rev Med Pharmacol Sci, 15, pp. 597-600, (2011)